Overall quality of life improves to similar levels after mechanical circulatory support regardless of severity of heart failure before implantation.

[1]  N. Cook,et al.  Decision Making in Advanced Heart Failure A Scientific Statement From the American Heart Association Endorsed by Heart Failure Society of America, American Association of Heart Failure Nurses, and Society for Medical Decision Making , 2022 .

[2]  Robert L Kormos,et al.  The Fourth INTERMACS Annual Report: 4,000 implants and counting. , 2012, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  A. Boyle,et al.  Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  L. Stevenson,et al.  Third INTERMACS Annual Report: the evolution of destination therapy in the United States. , 2011, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  P. Libby,et al.  Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 2-Volume Set, 9th Edition Expert Consult Premium Edition €“ Enhanced Online Features , 2011 .

[6]  M. Field,et al.  Approaching death: improving care at the end of life. , 2011, Health progress.

[7]  D. Mann,et al.  NHLBI's program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial. , 2010, Journal of cardiac failure.

[8]  S. Russell,et al.  Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. , 2010, Journal of the American College of Cardiology.

[9]  Martin J Buxton,et al.  A review of health utilities using the EQ-5D in studies of cardiovascular disease , 2010, Health and quality of life outcomes.

[10]  R. Hetzer,et al.  Outcomes of elective versus emergent permanent mechanical circulatory support in the elderly: a single-center experience. , 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[12]  Nader Moazami,et al.  Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. , 2009, Journal of the American College of Cardiology.

[13]  Karen Ulisney,et al.  INTERMACS profiles of advanced heart failure: the current picture. , 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[14]  Heather J Ross,et al.  Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure. , 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[15]  L. Martínez-Dolz,et al.  Study on health-related quality of life in patients with advanced heart failure before and after transplantation. , 2006, Transplantation proceedings.

[16]  D. Feeny,et al.  Self-Reported Health Status of the General Adult U.S. Population as Assessed by the EQ-5D and Health Utilities Index , 2005, Medical care.

[17]  Nick Freemantle,et al.  The impact of chronic heart failure on health‐related quality of life data acquired in the baseline phase of the CARE‐HF study , 2005, European journal of heart failure.

[18]  Annetine Gelijns,et al.  Left ventricular assist devices as destination therapy: a new look at survival. , 2005, The Journal of thoracic and cardiovascular surgery.

[19]  Annemarie Kaan,et al.  Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation. , 2004, The Annals of thoracic surgery.

[20]  Jeffrey A. Johnson,et al.  Comparison of the EQ-5D and SF-12 in an adult US sample , 1998, Quality of Life Research.

[21]  M C Oz,et al.  Long-term use of a left ventricular assist device for end-stage heart failure. , 2001, The New England journal of medicine.

[22]  A Mattea,et al.  Improvement in quality of life outcomes 2 weeks after left ventricular assist device implantation. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  R. Rabin,et al.  EQ-SD: a measure of health status from the EuroQol Group , 2001, Annals of medicine.

[24]  C. White-Williams,et al.  Quality of life 6 months after heart transplantation compared with indicators of illness severity before transplantation. , 1998, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[25]  A. Moskowitz,et al.  Quality of life with an implanted left ventricular assist device. , 1997, The Annals of thoracic surgery.

[26]  B. Spilker,et al.  Quality of life and pharmacoeconomics in clinical trials , 1996 .

[27]  G. Bonsel,et al.  Test-retest reliability of health state valuations collected with the EuroQol questionnaire. , 1994, Social science & medicine.

[28]  D. Krikler,et al.  Heart disease: A textbook of cardiovascular medicine , 1992 .

[29]  A. Williams.  EuroQol : a new facility for the measurement of health-related quality of life , 1990 .